BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1376 related articles for article (PubMed ID: 8246218)

  • 1. Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents.
    Shyam K; Penketh PG; Divo AA; Loomis RH; Rose WC; Sartorelli AC
    J Med Chem; 1993 Nov; 36(23):3496-502. PubMed ID: 8246218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dendritic cells and their role in pathology].
    Coronato S; Laguens GE; Spinelli OM; Salas MA; Di Girolamo W
    Medicina (B Aires); 1998; 58(2):209-18. PubMed ID: 9706258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of nuclear DNA and morphometry, and proliferating cell nuclear antigen in primary and metastatic malignant melanoma.
    Björnhagen V; Lindholm J; Auer G
    Scand J Plast Reconstr Surg Hand Surg; 1997 Jun; 31(2):109-18. PubMed ID: 9232695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma.
    Rüegg C; Yilmaz A; Bieler G; Bamat J; Chaubert P; Lejeune FJ
    Nat Med; 1998 Apr; 4(4):408-14. PubMed ID: 9546785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Schaefer C; Noppen C; Böni R; Kamarashev J; Nestle FO; Spagnoli GC; Dummer R
    Am J Pathol; 1997 Dec; 151(6):1549-53. PubMed ID: 9403705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-five years of isolated limb perfusion for melanoma: indications and results.
    Vrouenraets BC; Nieweg OE; Kroon BB
    Br J Surg; 1996 Oct; 83(10):1319-28. PubMed ID: 8944445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of serum for spreading of tumor cells on synthetic glycolipid films.
    Sato T; Endo M; Okahata Y
    J Biomater Sci Polym Ed; 1995; 7(7):587-99. PubMed ID: 8924425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of interactions between prognostic factors of stage I malignant melanoma.
    Helfenstein U; Schüler G; Bopp M; Morf S; Schüler D
    Melanoma Res; 1996 Aug; 6(4):319-24. PubMed ID: 8873052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant melanoma and atypical moles associated with a constitutional rearrangement of chromosomes 5 and 9.
    Petty EM; Bolognia JL; Bale AE; Yang-Feng T
    Am J Med Genet; 1993 Jan; 45(1):77-80. PubMed ID: 8418665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth regulatory proteins that repress differentiation markers in melanocytes also downregulate the transcription factor microphthalmia.
    Halaban R; Böhm M; Dotto P; Moellmann G; Cheng E; Zhang Y
    J Invest Dermatol; 1996 Jun; 106(6):1266-72. PubMed ID: 8752668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-probe-guided lymph node localization in malignant melanoma.
    Alex JC; Weaver DL; Fairbank JT; Rankin BS; Krag DN
    Surg Oncol; 1993 Oct; 2(5):303-8. PubMed ID: 8305972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 5-bromodeoxyuridine on messenger RNA production in cultured cells.
    Price PM
    Biochim Biophys Acta; 1976 Oct; 447(3):304-11. PubMed ID: 987803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of squamous cell vulval cancer: a population based retrospective study of 411 cases.
    Rhodes CA; Cummins C; Shafi MI
    Br J Obstet Gynaecol; 1998 Feb; 105(2):200-5. PubMed ID: 9501787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours.
    Fuller LC; Allen MH; Montesu M; Barker JN; Macdonald DM
    Br J Dermatol; 1996 Jan; 134(1):28-32. PubMed ID: 8745882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous and exogenous factors in carcinogenesis: limits to cancer prevention.
    Lutz WK; Fekete T
    Int Arch Occup Environ Health; 1996; 68(2):120-5. PubMed ID: 8720282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration.
    Caraceni A; Martini C; Belli F; Mascheroni L; Rivoltini L; Arienti F; Cascinelli N
    Eur J Cancer; 1993; 29A(9):1266-9. PubMed ID: 8343265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumors in the posterior pole.
    Edwards MG; Schachat AP
    Int Ophthalmol Clin; 1995; 35(4):123-35. PubMed ID: 8847188
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous and induced differentiation of human melanoma cells.
    Valyi-Nagy I; Shih IM; Györfi T; Greenstein D; Juhasz I; Elder DE; Herlyn M
    Int J Cancer; 1993 Apr; 54(1):159-65. PubMed ID: 8478142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic susceptibility and spontaneous release of human melanoma tumor-associated antigens.
    Stuhlmiller GM; Seigler HF
    J Natl Cancer Inst; 1977 Feb; 58(2):215-21. PubMed ID: 833872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
    Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
    Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.